ÃâÒßѧÊÔÌâ
X,"(G}KUA Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
x[5uz)) 1. Fas(CD95)/FasL
~t-!{F 2. common chain of cytokine receptor
xLmgr72D 3 . TCR/CD3 complex
I?_YL* 4. negaive selection of thymocytes
nVt,= ?_ U 5. artificial active immune
UfWn\*J&k 6. anti-idiotypic
^$I8ga 7. IgSF
X|w[:[P 8. Integrin
l@OY8z-_ 9. chemokine
K-CF5i: 10. B7/CD28
k6?;D_dm ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
:]hNw1e 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
gL:Vj%c 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
O<o>/HH$ 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
6,q}1- 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
*VP
jBzcH
T
7bDt 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
rV0X*[]J> µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
'M'k$G@Z Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
<X b B; 1. B7/CD28
X
DdF7i} 2. Th1 subset
V6ICR{y<3 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
PV\aQO.mo 4. antibody affinity maturation
x<fF1]; 5. AP-1
4{rqGC/ 6. single chain variable fragment£¨ScFv£©
7B)m/%>3s 7. NK cell receptor
Ump$N# 8. Zinkernagel-Doherty phenomenon
;LXwW(_6d 9. Ig fold
'=X)0GG 10. CD40/CD40L
U7do,jCoa ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
\Qvo
L 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
<1%(%KdN[ 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
aVvma=
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
.
\t8s0A Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
`i:DmIoz 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
u$38"&cmA 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
Pb`Uxv 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
pv[Gg^ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
[Xyu_I-c £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
d2a*xDkv Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
!*eDT4a 1.Co-stimulators (or co-stimulating molecules)
?` lD|~ 2.NK-kB
0Fw4}f.o 3.Immunoglobulin superfamily
}]
p9 4.antigen-presenting cell (APC)
XU y[l 5.death domain
m!K`?P]:N 6.CCR and CXCR
9?XQB%44 7.Lectin (or mitogen)
;p+[R+ ) 8.Clusters of differentiation, CD)
jP{&U&!i 9.B7 family
\47djmG- 10.Cytotoxic T lymphocyte, CTL)
YO'aX 11.IL-15 and IL-15 receptor (IL-15R)
2O
2HmL 12.MHC restriction
awv$ }EFo 13.Affinity-chromatography
y1)ZO_' 14.Cyctosprin A, CsA
rez)$ 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
-tZ~&
1" ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
^B)f!HtU 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
;,}Dh/&E 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
U4.$o]58 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
W#P`Y < u$ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
uOO\!Hqq ÃâÒßѧרҵ£º
N[rAb*iT 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
eaAGlEW6J Ïû»¯ÄÚ¿Æ£º
f{.4#C' 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
-VeCX] ѪҺ²¡Ñ§×¨Òµ£º
0NeIQr1N_ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
l*?_ @ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
9=mc3m:Tb( (רҵ»ù´¡: ÃâÒßѧ)
A;<wv>T Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
31~nay15 1. ADCC(antibody dependent cell-mediated cytotoxicity)
pM^Z C 2. »·æß¾úËØ(cyclosporin)
j4<K0-? 3. KIR(killer cell inhibitory receptor)
Mj{w/'
4. HLDA(human leucocyte differentiation antigen)
Sx[
eX,q 5. Interleukin 18(IL-18)
Khb Ku0Z 6. ÕûºÏËØ(integrin)
R_O=WmD 7. Fas/FasL
f S[-K?K 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
vK%*5 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
lYTQg~aPm 10. Th1/Th2
\{}dn,?Fv 11. »ùÒòÒßÃç(DNAÒßÃç)
pCDN9
*0/ 12. chemokines and chemokine receptor
lxm/*^
13. ÃâÒßÄÍÊÜ
9vz\R-un 14. ¹²´Ì¼¤·Ö×Ó
*f3S tX 15. ËÀÍö½á¹¹Óò(death domain)
D#G%WT/" ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
W|D
kq 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
hJ$9Hb 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
<|3%}? £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
NJ)Dw`|%|) £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
d\ 8v
VZ
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
p]%di8&;N £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
UXlZI'|He 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
uN:KivVe Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
Km;}xke6 ÎÊ´ðÌâ(ÿÌâ25·Ö)
0_eqO'" 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
$'%GB $. 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
ov,|`FdU^T 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
yo=L1;H 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£